Arbor Trust Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,462
Closed -$257K 98
2023
Q1
$257K Sell
3,462
-701
-17% -$58.8K 0.17% 81
2022
Q4
$388K Sell
4,163
-50
-1% -$4.83K 0.27% 67
2022
Q3
$402K Buy
4,213
+3
+0.1% +$297 0.31% 63
2022
Q2
$390K Buy
4,210
+59
+1% +$5.76K 0.27% 69
2022
Q1
$420K Buy
4,151
+52
+1% +$5.46K 0.25% 71
2021
Q4
$423K Buy
4,099
+3
+0.1% +$277 0.24% 71
2021
Q3
$348K Sell
4,096
-217
-5% -$18.2K 0.22% 74
2021
Q2
$360K Buy
4,313
+3
+0.1% +$246 0.23% 75
2021
Q1
$327K Buy
4,310
+3
+0.1% +$219 0.22% 72
2020
Q4
$294K Buy
+4,307
New +$280K 0.21% 68

Other funds holding CVS

Arbor Trust Wealth Advisors's CVS Position: Q2 2023 in Review

Arbor Trust Wealth Advisors sold out of CVS Health (CVS) in Q2 2023, closing a stake of 3,462 shares — an estimated $257K sold.

Arbor Trust Wealth Advisors first reported a position in CVS in Q4 2020 and held it in 10 quarters. The position peaked at $423K in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Arbor Trust Wealth Advisors reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Arbor Trust Wealth Advisors sold 3,462 CVS Health shares in Q2 2023, an estimated $257K.
  • Arbor Trust Wealth Advisors first reported a position in CVS Health in Q4 2020 and held it in 10 quarters.
  • Arbor Trust Wealth Advisors's CVS Health position peaked at $423K in Q4 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Arbor Trust Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.